CLNN_OUT_1 [2025-04-02 13:30:37 -0400] 2103 Bytes | 599 tokens | Cum: 599 tkns (7.49% of 8k)
==========================================================================

We need a winner today and it's already 1:30:36 PM on Wed Apr 02, 2025 -0400 ... So let's find out if Clene (CLNN) is going up or if it's going nowhere fast. So, I pulled together a bunch of data for you to look over real fast. It's at 3.1 up from 2.58. Is there something here we can get excited about? Help me analyze.

--- COMPANY PROFILE ---
Company: Clene (CLNN)
IPO: IPO date unknown
Shares Outstanding: 8,630,000
Industry: PHARMACEUTICAL PREPARATIONS
Exchange: XNAS

Here's the first list of news for Clene:

C1 - Apr-01-25 08:30AM - Clene to Present at the Jones Healthcare and Technology Innovation Conference
C2 - Mar-25-25 08:30AM - Clene to Participate in Jones Las Vegas Technology and Innovation Conference on April 8-9, 2025
C3 - Mar-24-25 09:10AM - Clene Inc. (CLNN) Reports Q4 Loss, Lags Revenue Estimates
C4 - Mar-24-25 09:10AM 08:00AM - Clene Reports Full Year 2024 Financial Results and Recent Operating Highlights
C5 - Mar-18-25 03:30PM - Q1 Virtual Investor Summit: On-Demand Presentations Now Live
C6 - Mar-12-25 08:00AM - Clene Demonstrates Strengthened ALS Survival Benefit with CNM-Au8 Treatment
C7 - Mar-06-25 08:30AM - Clene to Present at the 37TH Annual Roth Conference
C8 - Feb-27-25 09:15AM - Clene Inc. Rob Etherington, CEO, and Morgan Brown, CFO, to Present at the Investor Summit Virtual on March 11

ONLY 3 RULES for AI:
==============
1) I am a document retrieval system. You are the analyst-investigator.
2) You can request items from my lists to get more info on Clene (CLNN)
3) AFTER requesting and reading News and SEC filings you'll write a summary, set a score, high price target and headline.
Now, your response should be only 2 or 3 chars. You can say ex., C1, C2, etc., or NEX
The NEX command delivers the NEXt list of News/SEC/Metrics
There are several more lists that use our unified document retrieval system in subsequent prompts.
Your predictons will be compared to reality to rate your accuracy. Try to predict accurately. GOOD LUCK!
Please request a document, read, summarize and score. Say something like "C1".

CLNN_OUT_3 [2025-04-02 13:30:42 -0400] 1100 Bytes | 323 tokens | Cum: 924 tkns (11.55% of 8k)
==========================================================================

Showing C6 (chunk 1 of 11): C6:
**Clene Demonstrates Strengthened ALS Survival Benefit with CNM-Au8 Treatment**
Date: Mar-12-25 08:00AM
Source: (GlobeNewswire)
URL: https://www.globenewswire.com/news-release/2025/03/12/3041298/0/en/Clene-Demonstrates-Strengthened-ALS-Survival-Benefit-with-CNM-Au8-Treatment.html

March 12, 2025 08:00 ET| Source:Clene Inc.Clene Inc.

SALT LAKE CITY, March 12, 2025 (GLOBE NEWSWIRE) -- Clene, Inc. (Nasdaq: CLNN) and its subsidiary, Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company focused on revolutionizing the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS), today announced new evidence from a cross-regimen,post hocanalysis of long-term survival in HEALEY ALS Platform Trial participants. The analyses further substantiate that treatment with CNM-Au8®30 mg delivers a significant survival benefit for

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

CLNN_OUT_5 [2025-04-02 13:30:46 -0400] 925 Bytes | 266 tokens | Cum: 1260 tkns (15.75% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-04-01T20:00:54Z - Best Nanotechnology Stocks To Research - March 31st...
A2 - 2025-04-01T14:24:07Z - CLNN stock touches 52-week low at $2.95 amid market challenges By Investing.com...
A3 - 2025-04-01T14:23:41Z - CLNN stock touches 52-week low at $2.95 amid market challenges By Investing.com...
A4 - 2025-04-01T14:25:26Z - InvestorNewsBreaks - Clene Inc. (NASDAQ: CLNN) to Present at Jones Healthcare and Technology Innovat...
A5 - 2025-04-01T12:43:13Z - Clene to Present at the Jones Healthcare and Technology Innovation Conference...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

CLNN_OUT_7 [2025-04-02 13:30:46 -0400] 1098 Bytes | 271 tokens | Cum: 1533 tkns (19.16% of 8k)
==========================================================================

Showing A1 (chunk 1 of 9): A1:
**Best Nanotechnology Stocks To Research - March 31st**Date: 2025-04-01Source: {'uri': 'marketbeat.com', 'dataType': 'news', 'title': 'Market Beat'}URL: https://www.marketbeat.com/instant-alerts/best-nanotechnology-stocks-to-research-march-31st-2025-03-31/OSI Systems, NVE, Biodexa Pharmaceuticals, Virpax Pharmaceuticals, Clene, and Clene are the seven Nanotechnology stocks to watch today, according to MarketBeat's stock screener tool. Nanotechnology stocks refer to shares in companies that develop and commercialize technologies at the nanoscale, often involving the manipulation of matter at the atomic or molecular level. These companies typically operate in fields such as electronics, healthcare, and advanced materials, offering potential growth from innovative breakthroughs while also carrying risks related to emerging technologies and market volatility. These companies had the high

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

CLNN_OUT_9 [2025-04-02 13:30:48 -0400] 1072 Bytes | 340 tokens | Cum: 1875 tkns (23.44% of 8k)
==========================================================================

This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!

B1 - 2024-09-03T12:00:00Z - Clene to Present at the H.C. Wainwright 26th Annual Global Investment Conference
B2 - 2024-07-17T11:03:36Z - Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now - GlobeNewswire
B3 - 2024-07-09T16:11:44Z - Crude Oil Down 1%; Soligenix Shares Surge - Helen Of Troy (NASDAQ:HELE) - Benzinga
B4 - 2024-06-24T12:00:00Z - Clene to Present at H.C. Wainwright’s 5th Annual Neuro Perspectives Virtual Conference
B5 - 2024-06-21T11:09:00Z - Clene Presents Preliminary Data for CNM-Au8® as a Potential Treatment for Rett Syndrome
B6 - 2024-06-18T11:00:00Z - Clene Presents Extended Survival Data Through 3.5 Years and New NfL Responder Results with CNM-Au8® 30 mg Treatment from the HEALEY ALS Platform Trial Open Label Extension at the 2024 ENCALS Meeting

Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

CLNN_OUT_11 [2025-04-02 13:30:52 -0400] 691 Bytes | 208 tokens | Cum: 2085 tkns (26.06% of 8k)
==========================================================================

Showing B3 (chunk 1 of 1): B3:
**Crude Oil Down 1%; Soligenix Shares Surge - Helen Of Troy (NASDAQ:HELE) - Benzinga**Date: Unknown DateSource: Unknown SourceURL: https://www.benzinga.com/news/earnings/24/07/39693386/crude-oil-down-1-soligenix-shares-surgeCrude oil prices declined by 1%, while shares of Soligenix surged 282% after the company announced positive interim results for its HyBryte treatment. Helen of Troy reported soft Q1 earnings and lowered its FY25 guidance, leading to a 30% drop in its stock price.

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

CLNN_OUT_13 [2025-04-02 13:30:53 -0400] 804 Bytes | 200 tokens | Cum: 2362 tkns (29.53% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

S1 - 2025-03-24 8-K Item 2.02 Results of Oper and Fin Cond.

On March 24, 2025, Clene Inc. (the Company) issued a press release announcing its full year operating and financial results for its year ended December 31, 2024. A copy of the press release is furnished as Exhibit 99.1 to...

S2 - 2025-03-24 10-K Item 7. Management s Discussion and Analysis of Fin Cond and Results of Oper

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our CONS financial statements and related notes i...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

CLNN_OUT_15 [2025-04-02 13:30:58 -0400] 1098 Bytes | 270 tokens | Cum: 2634 tkns (32.92% of 8k)
==========================================================================

Showing S1 (chunk 1 of 2): S1:
Item 2.02 Results of Operations and Financial Condition.

On March 24, 2025, Clene Inc. (the Company) issued a press release announcing its full year operating and financial results for its year ended December 31, 2024. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information furnished in this Item 2.02, including Exhibit 99.1, shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934 (the Exchange Act), as amended, or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any filing made by the Company under the Exchange Act or the Securities Act of 1933, as amended, regardless of any general incorporation language in any such filings, except as shall be expressly set forth by specific refere

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

CLNN_OUT_17 [2025-04-02 13:31:12 -0400] 5351 Bytes | 1600 tokens | Cum: 4371 tkns (54.64% of 8k)
==========================================================================

This is our set of metrics.
Please analyze the numbers.

+--------------------+-----------------------+------------------------+-------------------------+
| Volume: 47,000 | Perf Month: -27.70% | Option/Short: No / Yes | Sales Y/Y TTM: -47.71% |
+--------------------+-----------------------+------------------------+-------------------------+
| Avg Volume: 55.55K | Perf Quarter: -38.40% | Short Float: 1.53% | ROE: -1738.36% |
+--------------------+-----------------------+------------------------+-------------------------+
| Rel Volume: 1.41 | Index: - | Short Ratio: 1.56 | ROI: -368.19% |
+--------------------+-----------------------+------------------------+-------------------------+
| RSI (14): 33.98 | Market Cap: 26.59M | Short Interest: 0.09M | Sales Surprise: -34.20% |
+--------------------+-----------------------+------------------------+-------------------------+
| ATR (14): 0.34 | Shs Outstand: 8.09M | Beta: 0.47 | EPS Surprise: -64.41% |
+--------------------+-----------------------+------------------------+-------------------------+
| SMA20: -22.07% | Shs Float: 5.64M | Sales Q/Q: -46.47% | P/E: - |
+--------------------+-----------------------+------------------------+-------------------------+
| SMA50: -28.60% | Inst Own: 5.85% | Sales past 5Y: 41.39% | Earnings: Mar 24 BMO |
+--------------------+-----------------------+------------------------+-------------------------+
| SMA200: -39.05% | Insider Own: 34.71% | Employees: 76 | |
+--------------------+-----------------------+------------------------+-------------------------+
| Perf Week: -12.99% | Insider Trans: 3.08% | Debt/Eq: - | |
+--------------------+-----------------------+------------------------+-------------------------+

The next section covers any insider trading.
If this section may be blank due to no recent filings.

Inside Trans: Clene Inc. (CLNN) by General Resonance LLC (Unknown Title) on 2025-03-18
- Common Stock: 1333 shares at $4.45 (D)
- Common Stock: 1400 shares at $4.4 (D)

Inside Trans: Clene Inc. (CLNN) by Desai Arjun JJ (Unknown Title) on 2025-02-27
- Stock Options (Right to buy): 3319 shares at $0 (D)

Inside Trans: Clene Inc. (CLNN) by Gay Jonathon (Unknown Title) on 2025-02-27
- Stock Options (Right to buy): 3716 shares at $0 (D)

Inside Trans: Clene Inc. (CLNN) by Jacobovitz Shalom (Unknown Title) on 2025-02-27
- Stock Options (Right to buy): 4293 shares at $0 (D)

Inside Trans: Clene Inc. (CLNN) by MATLIN DAVID J (Unknown Title) on 2025-02-27
- Stock Options (Right to buy): 5628 shares at $0 (D)

Inside Trans: Clene Inc. (CLNN) by McLaughlin Vallerie (Unknown Title) on 2025-02-27
- Stock Options (Right to buy): 3175 shares at $0 (D)

Inside Trans: Clene Inc. (CLNN) by Kiernan Matthew (Unknown Title) on 2025-02-27
- Stock Options (Right to buy): 2886 shares at $0 (D)

Inside Trans: Clene Inc. (CLNN) by Mosca Alison (Unknown Title) on 2025-02-27
- Stock Options (Right to buy): 4402 shares at $0 (D)

[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): {'value': 342000, 'unit': 'USD', 'label': 'Revenues', 'order': 100}
Net Income: {'value': -39400000.0, 'unit': 'USD', 'label': 'Net Income/Loss', 'order': 3200}
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 3.0737
Average Volume: 51704.78
30-Day High: 4.58
30-Day Low: 2.58

[Detailed Financials: TTM 2024]
- Total Assets: $27,337,000.0
- Total Liabilities: $36,194,000.0
- Total Equity: $-8,857,000.0
- Current Assets: $16,157,000.0
- Current Liabilities: $10,291,000.0

[Income Statement: TTM 2024]
- Revenue: $342,000.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -5.67

[Cash Flow Statement: TTM 2024]
- Net Cash Flow: $-16,539,000.0

[Detailed Financials: FY 2024]
- Total Assets: $27,337,000.0
- Total Liabilities: $36,194,000.0
- Total Equity: $-8,857,000.0
- Current Assets: $16,157,000.0
- Current Liabilities: $10,291,000.0

[Income Statement: FY 2024]
- Revenue: $342,000.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -5.67

[Cash Flow Statement: FY 2024]
- Net Cash Flow: $-16,539,000.0
==== END OF FINANCIAL REPORT ====

You are now requested to make a summary analysis.
Save explaining why you didn't have enough information for the final survey.

Now, complete this report with the following:

1) Brief Summary: explain your findings in succinct wording.
2) MARKET_SCORE: If you calculate a 92% likelihood of an upward moves, say: MARKET_SCORE[92]
3) PRICE_TARGET: If you think the high today will be 50% higher, add to the price.
Eg., If the current price is $5.00, add 50%. Thus, PRICE_TARGET[$7.50] -- It should be at or above the current price.
4) Provide a thought-provoking take, 6-10 words, to use for the headline of this news story.
Like this: AI_RPT_HEADLINE: [6-12 words headline for news story, distilled from summary]

1) Brief Summary, 2) MARKET_SCORE, 3) PRICE_TARGET, and 4) AI_RPT_HEADLINE

CLNN_OUT_19 [2025-04-02 13:31:14 -0400] 676 Bytes | 167 tokens | Cum: 4829 tkns (60.36% of 8k)
==========================================================================

Finally, if more data could have improved your confidence which would you have chosen? **Choose one option:**
-> X0 <- Nothing more would have helped my analysis
-> X1 <- More stock-specific news
-> X2 <- More SEC filings (10-K, 10-Q, 8-K) Financials, risk disclosures, and business changes
-> X3 <- More SEC Insider Trading (Form 3, 4, 5) Direct buys/sells from executives and institutions
-> X4 <- Broader sector & market news
-> X5 <- Your past analysis on similar companies (specify metrics)
-> X6 <- More financial metrics
-> X7 <- Your past analysis on this exact company
-> X8 <- Something altogether different (explain...)

CLNN_IN_21 [2025-04-02 13:31:15 -0400] 126 Bytes | 29 tokens | Cum: 4926 tkns (61.58% of 8k)
==========================================================================

====================================
[2025-04-02 13:31:15] # Analysis Completed
Elapsed Time: 38.40 seconds